Notifications
Clear all
Topic starter
21/08/2026 4:46 pm
TL;DR: Generative AI is moving into healthcare for back-office automation, documentation support, predictive augmentation, and patient engagement, but Fiddler argues that reliability, security, and compliance must be built into every use case before scale. The central issue is not capability, but whether institutions can constrain hallucinations, validate outputs, and govern high-stakes decisions with risk-based oversight.
NHIMG editorial — based on content published by Fiddler: Harnessing Generative AI for Healthcare Innovation
Questions worth separating out
Q: How should healthcare organisations govern GenAI in high-stakes workflows?
A: Start by classifying each use case by impact, reversibility, and urgency, then apply stricter validation where errors could affect patient care or compliance.
Q: Why do AI assistants in healthcare need IAM and NHI controls?
A: Because many AI workflows act through credentials, service accounts, and API permissions to read data, write notes, or invoke other tools.
Q: What do teams get wrong about hallucinations in healthcare GenAI?
A: They often treat hallucinations as a pure model-quality problem when the real issue is governance.
Practitioner guidance
- Define AI use cases by decision criticality Separate low-risk administrative automation from high-stakes clinical or compliance support, and assign different approval, testing, and escalation requirements to each class.
- Map AI-linked identities and permissions Inventory the service accounts, API keys, and tool permissions used by GenAI workflows, then remove any access that is not required for a specific task or data source.
- Require retrieval grounding for sensitive outputs Use approved clinical, policy, or operational sources for retrieval-augmented generation when the model is drafting patient-facing or decision-support content.
What's in the full article
Fiddler's full blog covers the operational detail this post intentionally leaves for the source:
- Concrete healthcare use-case examples for ambient documentation, patient engagement, and predictive augmentation
- The article's discussion of RAG and third-party guardrails for reducing hallucinations in regulated workflows
- Practical governance principles for risk-based oversight, continuous monitoring, and team education
- The interview context with Dr. Girish N. Nadkarni and the healthcare implementation framing around Mount Sinai
👉 Read Fiddler's analysis of generative AI governance in healthcare →
Generative AI in healthcare: where governance and oversight still lag?
Explore further
21/08/2026 5:05 pm
Healthcare GenAI governance fails when institutions treat model output as the control boundary. The real risk is not just that an LLM can hallucinate, but that the organisation may route sensitive work through a system whose reliability is not assured. Risk-based oversight, grounded retrieval, and human review are not optional extras in high-stakes settings. Practitioners should design governance around decision criticality, not model novelty.
A question worth separating out:
Q: How do you know if healthcare GenAI oversight is working?
A: Look for evidence that sensitive workflows have clear approval points, traceable source grounding, and documented exception handling when outputs are uncertain. If teams can explain who approved the AI action, what data it used, and how errors are reviewed, oversight is working. If not, the programme is still operating on trust rather than control.
👉 Read our full editorial: Generative AI in healthcare needs stronger governance and oversight
